We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
“Drug warning!” blares the voice from a late-night TV ad. “Have you or a loved one been injured by XYZ drug? You may be entitled to substantial compensation!”
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda.
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda. Both put out broad and hopeful
“Drug warning!” blares the voice from a late-night TV ad. “Have you or a loved one been injured by XYZ drug? You may be entitled to substantial compensation!”